Our Bureau, Bengaluru Thursday, March 20, 2025, 17:40 Hrs [IST] ...

Bharat Biotech invests $75 million in India's first Cell & Gene Therapy facility, focusing on advanced therapies and ...

Dr. Raches Ella, Chief Development Officer, Bharat Biotech, spearheading this CGT initiative, said that oncology and rare ...

I T WAS AFTER tripping on hallucinogenic mushrooms that Christian Angermayer realised he had a personal mission to help the ...

A self-made millionaire has made significant lifestyle changes to boost his health, wellbeing and fitness in a bid to live to ...

FDA granted priority review to Company's BLA for PRGN-2012 for the treatment of adults with recurrent respiratory papillomatosis and set PDUFA target action date ...

A single piece of genetic material influences whether someone develops type 1 diabetes, Dutch researchers discovered. People ...

By replacing the defective gene associated with Dravet syndrome in mice, scientists successfully alleviated symptoms without side effects.

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

While the allogeneic vs autologous debate continues in the cell therapy field, research on in vivo therapies is drawing ...

Gene expression testing helps determine chemotherapy needs for hormone receptor-positive breast cancer, optimizing treatment ...

In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form of epilepsy, scientists have developed a new gene replacement therapy in ...